CGON short interest
CG Oncology Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 10,441,484 |
|---|---|
| Change vs prior report | -813,016 (-7.2%) |
| Change over six months | -0.9% |
| Days to cover | 8.46 (sector: 3.78) |
| Average daily volume | 1,234,894 |
| Rank in Healthcare | #178 of 922 by days to cover |
CGON short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 10,441,484 | -7.2% | 8.46 | 1,234,894 |
| 2026-09-15 | 11,254,500 | -1.2% | 17.01 | 661,528 |
| 2026-08-31 | 11,396,156 | +1.3% | 16.07 | 709,063 |
| 2026-08-14 | 11,248,462 | -5.0% | 14.85 | 757,562 |
| 2026-07-31 | 11,844,115 | -2.2% | 13.53 | 875,547 |
| 2026-07-15 | 12,105,610 | +0.3% | 12.24 | 989,354 |
| 2026-06-30 | 12,068,774 | +14.3% | 7.61 | 1,586,308 |
| 2026-06-15 | 10,559,078 | +7.6% | 11.61 | 909,472 |
| 2026-05-29 | 9,810,951 | +6.9% | 10.15 | 966,552 |
| 2026-05-15 | 9,179,394 | -0.5% | 10.00 | 917,955 |
| 2026-04-30 | 9,222,491 | -3.3% | 10.13 | 910,164 |
| 2026-04-15 | 9,534,138 | -9.5% | 7.60 | 1,254,750 |
| 2026-03-31 | 10,536,784 | -0.2% | 6.87 | 1,534,667 |
| 2026-03-13 | 10,554,681 | +13.6% | 6.35 | 1,662,045 |
| 2026-02-27 | 9,293,407 | -2.1% | 13.14 | 707,511 |
| 2026-02-13 | 9,496,710 | +2.8% | 11.14 | 852,652 |
| 2026-01-30 | 9,242,783 | -1.5% | 7.08 | 1,304,755 |
| 2026-01-15 | 9,387,150 | -27.3% | 5.59 | 1,679,102 |
| 2025-12-31 | 12,919,357 | -1.7% | 14.45 | 893,837 |
| 2025-12-15 | 13,145,322 | -4.1% | 17.44 | 753,729 |
| 2025-11-28 | 13,713,699 | +3.9% | 17.17 | 798,897 |
| 2025-11-14 | 13,205,390 | +5.8% | 14.03 | 941,438 |
| 2025-10-31 | 12,477,457 | +2.1% | 14.84 | 840,612 |
| 2025-10-15 | 12,222,593 | +1.9% | 10.73 | 1,138,798 |
| 2025-09-30 | 11,991,344 | +8.9% | 11.79 | 1,017,284 |
import finzdata as yf
yf.Ticker("CGON").short_interest # every report since 2017
yf.Client().short_interest(["CGON"], start="2018-01-01")Healthcare short interest · CGON price history · Who owns CGON · All short interest